title: Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack.
abstract: The tolerance of cancer cells to hypoxia depends on the combination of different factors--from increase of glycolysis (Warburg Effect) to activation of intracellular growth/apoptotic pathways. Less is known about the influence of epithelial-mesenchymal transition (EMT) and EMT-associated pathways on the cell sensitivity to hypoxia. The aim of this study was to explore the role of Snail signaling, one of the key EMT pathways, in the mediating of hypoxia response and regulation of cell sensitivity to hypoxia, using as a model in vitro cultured breast cancer cells. Earlier we have shown that estrogen-independent HBL-100 breast cancer cells differ from estrogen-dependent MCF-7 cells with increased expression of Snail1, and demonstrated Snail1 involvement into formation of hormone-resistant phenotype. Because Snail1 belongs to hypoxia-activated proteins, here we studied the influence of Snail1 signaling on the cell tolerance to hypoxia. We found that Snail1-enriched HBL-100 cells were less sensitive to hypoxia-induced growth suppression if compared with MCF-7 line (31% MCF-7 vs. 71% HBL-100 cell viability after 1% O2 atmosphere for 3 days). Snail1 knock-down enhanced the hypoxia-induced inhibition of cell proliferation giving the direct evidence of Snail1 involvement into cell protection from hypoxia attack. The protective effect of Snail1 was shown to be mediated, at least in a part, via beta-catenin which positively regulated expression of HIF-1-dependent genes. Finally, we found that cell tolerance to hypoxia was accompanied with the failure in the phosphorylation of AMPK - the key energy sensor, and demonstrated an inverse relationship between AMPK and Snail/beta-catenin signaling. Totally, our data show that Snail1 and beta-catenin, besides association with loss of hormone dependence, protect cancer cells from hypoxia and may serve as an important target in the treatment of breast cancer. Moreover, we suggest that the level of these proteins as well the level of AMPK phosphorylation may be considered as predictors of the tumor sensitivity to anti-angiogenic drugs.
authors: Laboratory of Clinical Biochemistry, Institute of Clinical Oncology, N.N. Blokhin Cancer Research Centre, Kashirskoye sh. 24, Moscow 115478, Russia. Electronic address: alex.scherbakov@gmail.com.
authors: Alexander M
authors: AM
authors: Scherbakov
authors: Lidia B
authors: LB
authors: Stefanova
authors: Danila V
authors: DV
authors: Sorokin
authors: Svetlana E
authors: SE
authors: Semina
authors: Lev M
authors: LM
authors: Berstein
authors: Mikhail A
authors: MA
authors: Krasil'nikov
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000378:metabolism*; D061986:MCF-7 Cells; D015398:Signal Transduction; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors / Q000378:metabolism*; D051176:beta Catenin / Q000378:metabolism*
chemical_list: C495270:CTNNB1 protein, human; C000604407:SNAI1 protein, human; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors; D051176:beta Catenin
keywords: 3-[4,5–dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; 5′-adenosine monophosphate-activated protein kinase; AMPK; Beta-catenin; Breast cancer; DL-dithiothreitol; DTT; EDTA; EMT; ER alpha; Epithelial-mesenchymal transition; FCS; HIF-1; HRE; Hypoxia; MTA3; MTT; PBS; PFA; PMSF; Snail1; T-cell-specific transcription factor; TBS; TCF; TRITC; Tris-buffered saline; epithelial-mesenchymal transition; estrogen receptor alpha; ethylenediaminetetraacetic acid; fetal calf serum; hypoxia-inducible factor-1; hypoxia-responsive element; metastasis-associated protein 3; paraformaldehyde; phenylmethanesulfonyl fluoride; phosphate buffered saline; siRNA; small interfering RNA; tetramethylrhodamine isothiocyanate mixed isomers